Artelo Biosciences's total assets for Q2 2024 were $8.33M, a decrease of -19.59% from the previous quarter. ARTL total liabilities were $1.03M for the fiscal quarter, a 25.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.